INSERM ( Institut National de la Sante et de la Recherche Medicale;URGO RECHERCHE INNOVATION ET DEVELOPPEMENT;Centre National de la Recherche Scientifique-CNRS;Université Paris Diderot-Paris 7;Ecole N
发明人:
Claire Dugast-Darzacq,Maïté Noizet,Xavier Darzacq
申请号：
US15809541
公开号：
US20180057819A1
申请日:
2017.11.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to a therapeutic compound comprising: an agent that inhibits the activity of at least one gene selected from the group consisting of HIC1, FOXS1, CREB5, IRF7, POU2F2, STAT4, TCF4, and/or an agent that enhances the activity of at least one gene selected from the group consisting of MAF, MEOX2, SIX2.
